Donald Allen Williams, Director at PALISADE BIO, INC. (PALI), bought 20,000 shares at $1.42 ($29K) on 2026-10-01, disclosed to the SEC on 2026-10-05.
Director Donald Allen Williams purchased $14,200 of PALISADE BIO, INC. stock at $1.42, marking the largest insider purchase in the company's history. This significant accumulation by a director suggests confidence in the stock's recovery potential following a steep decline.
The stock is trading at $1.45, down 30.46% over the last 30 days and 49.12% from its 52-week high of $2.85, currently sitting just 9.85% above its 52-week low of $1.32.
Insider purchased 10,000 shares at $1.42, the largest purchase in company history; stock is down 30.46% over the last 30 days and 49.12% from its 52-week high of $2.85, currently sitting just 9.85% above its 52-week low of $1.32.
The stock has a high beta of 1.62 and a short interest of 17.37% of the float, indicating significant volatility and potential selling pressure.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.42 | 10,000 | $14K | 49.3% |
| 2 | $1.46 | 10,000 | $15K | 50.7% |
| Total | $1.44 avg | 20,000 | $29K | 100% |
| Filing → |
| PALI | BUY | 2024-05-29 | $5K | — | Filing → |
| PALI | BUY | 2024-02-01 | $6K | — | Filing → |
| PALI | BUY | 2023-09-29 | $11K | — | Filing → |